27 July 2017 - Healthcare professionals should offer statins to millions of people with chronic kidney disease.
This will help to manage their increased risk of cardiovascular disease, says NICE.
The new NICE standard lists atorvastatin as the preferred statin to offer patients because it is both clinically and cost effective.